Pfizer to exit GSK's consumer health arm Haleon after spin-off
2022 The Globe and Mail Inc.
business
2022-06-01 11:26:48

Pfizer PFE-N plans to exit its 32% stake in Haleon, a consumer health joint venture with British drugmaker GSK, after the business is spun off as an independent listed company in July, GSK said on Wednesday.Pfizer previously signaled it would seek to sell its shareholding in Haleon, the world's largest consumer health business and home to Sensodyne toothpaste and Advil painkillers.But GSK, which has a 68% controlling interest in Haleon, had said in February the U.S. drugmaker would retain its stake.
